DIAGNOSTIC BIOCHIPS, INC.

Diagnostic Biochips, Inc. specializes in the design and development of advanced diagnostic biochips for investigational laboratory applications, with a focus on deep array probe technologies that enable high-sensitivity molecular detection. The company’s core expertise lies in microfluidic system integration, surface chemistry optimization for probe immobilization, and multiplexed analyte sensing platforms tailored for biomedical research. Their work involves engineering silicon- or polymer-based chip architectures capable of parallelized biomolecular interrogation, supporting applications in genomics, proteomics, and infectious disease diagnostics. Key differentiators include proprietary probe array patterning methods and closed-system sample-to-answer workflows that enhance reproducibility and reduce contamination risk in low-resource settings. The contractor has demonstrated direct engagement with the Department of Health and Human Services, delivering custom diagnostic platforms under investigational use protocols. This relationship suggests alignment with NIH or CDC research initiatives focused on next-generation diagnostics, where rapid, scalable, and multiplexed detection tools are critical for public health surveillance and precision medicine development. Their primary industry focus is analytical laboratory instrument manufacturing, specifically within the niche of biosensor-based diagnostic devices. This positions them at the intersection of microfabrication, molecular biology, and clinical diagnostics, serving research-driven segments of the life sciences market that require high-density, low-volume assay platforms not met by commercial off-the-shelf systems. Diagnostic Biochips, Inc. is a small business structured as a 2L entity, headquartered in Glen Burnie, Maryland. While currently holding no formal government certifications, their technical work aligns with FDA-regulated diagnostic device development pathways and supports federally funded biomedical research. Their geographic presence in the Mid-Atlantic corridor provides proximity to key federal research hubs and academic medical centers, reinforcing their role as a specialized supplier of novel diagnostic instrumentation for government-sponsored innovation.